Surgery Partners, Inc. SGRY

14.40 0.20 1.41% as of 25 Sep
Market cap
$1.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Net Income
85.08 28.70 (95.60) 45.10 1.30 70.70 87.00 135.30 12.50 98.90
Depreciation & Amortization
39.55 51.90 67.40 76.50 94.80 98.80 114.80 118.10 152.60 176.00
Non Cash Items (Other)
44.02 61.50 139.60 76.70 74.90 98.90 117.70 103.90 253.90 109.80
Accounts Receivable Change
(60.62) (22.70) (22.80) (23.50) (46.60) (32.10) (35.30) (47.20) (72.10) (53.80)
Change in payables and accrued liability
50.00 85.00 83.00 97.00 135.20 (73.60) (58.40) (1.20) — —
Change in other assets and liabilities
17.20 1.50 56.00 (45.30) (12.70) (75.60) (67.00) (16.30) (46.80) (56.60)
Operating Cash Flow
125.24 120.90 144.60 129.50 246.90 87.10 158.80 293.80 300.10 274.30
Capital expenditures
(39.11) (29.60) (20.60) (56.00) 15.60 (51.60) (67.70) (63.00) (87.80) (32.20)
Net Aquisitions
(145.64) (753.80) (106.80) (13.80) (104.60) (285.80) (146.40) (80.00) (378.80) (162.10)
Long-Term Investments Change (Net)
— — — (15.20) — 5.40 (82.30) (48.90) 2.90 (11.80)
Other investing activities
(85.87) (85.73) (1.50) (0.20) 0.60 0.30 (11.50) (33.70) (24.80) (40.50)
Investing cash flow
(184.75) (783.40) (128.90) (85.20) (88.40) (331.70) (307.90) (225.60) (488.50) (246.60)
Repayment/Issuance of Debt (Net)
177.27 623.60 125.10 (1.70) 213.10 (43.80) (655.50) 19.50 450.40 162.80
Equity Repurchase (Common, Net)
— (2.00) (2.00) — — 581.80 882.90 — — —
Equity Repurchase (Preffered, Net)
— 310.00 — — — — — — — —
Dividends Paid (Total)
(65.78) (85.10) (116.80) (121.20) (109.60) (136.10) (146.80) (146.10) (170.50) (226.00)
Other financial activities
(40.22) (78.80) (12.60) (13.00) (36.80) (85.60) (38.50) (28.60) (17.90) 5.90
Financing cash flow
71.28 767.70 (6.30) (135.90) 66.70 316.30 42.10 (155.20) 262.00 (57.30)
Change in Cash
11.77 105.20 9.40 (91.60) 225.20 71.70 (107.00) (87.00) 73.60 (29.60)
Beginning Cash
58.25 284.50 175.20 184.60 93.00 318.20 389.90 282.90 195.90 269.50
Ending Cash
70.01 389.70 184.60 93.00 318.20 389.90 282.90 195.90 269.50 239.90
Stock Based Compensation
2.02 5.60 9.30 10.20 13.20 17.40 18.40 17.70 33.30 14.80
Dividends Paid (Common)
(65.78) (83.80) (109.00) (121.20) (109.60) (131.00) (146.80) (146.10) (170.50) (226.00)
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(43.42) (21.20) 33.20 (68.80) 75.90 (181.30) (160.70) (63.50) (118.90) (110.40)
Investments Change (Net)
— — — (15.20) — 5.40 (82.30) (48.90) 2.90 (11.80)
Dividends Paid (Preffered)
— (1.30) (7.80) — — (5.10) — — — —
Issuance/Purchase of Shares
— 308.00 (2.00) — — 581.80 882.90 — — —
Other line items
Revenue per Employee
0.19 0.13 0.16 0.19 0.17 0.20 0.21 0.20 0.21 0.21

Fold the line items

In millions of $ except per-share values · columns are period end dates